 |
|
Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
Woo Yeong Park, Yaerim Kim, Jin Hyuk Paek, Kyubok Jin, Seungyeup Han
Kidney Res Clin Pract. 2021;40(2):317-324. Published online 2021 Apr 15 DOI: https://doi.org/10.23876/j.krcp.20.183
|
|
Citations to this article as recorded by
 Serum galactose-deficient immunoglobulin A1 in recurrent immunoglobulin a nephropathy after kidney transplantation: A meta-analysis
Zhiyan Gong, Jianying Tang, Wei Hu, Xiaoyan Song, Xiyan Liu, Jiao Mu, Yuanyuan Su
Transplant Immunology.2023; 79: 101850. CrossRef Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection
Jeong-Hoon Lim, Byung Ha Chung, Sang-Ho Lee, Hee-Yeon Jung, Ji-Young Choi, Jang-Hee Cho, Sun-Hee Park, Yong-Lim Kim, Chan-Duck Kim
The Korean Journal of Internal Medicine.2022; 37(3): 520. CrossRef Biomarker for recurrent immunoglobulin A nephropathy in kidney allografts: promising but still a long way to go
Byung Ha Chung
Kidney Research and Clinical Practice.2021; 40(2): 180. CrossRef
|